Update of the ENESTnd Study: Comparison of Nilotinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)
Update of the ENESTnd Study: Comparison of Nilotinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)
Slides from a presentation at ASCO 2010 and transcribed comments from a recent interview with Hagop M Kantarjian, MD (6/30/10)
Larson RA et al. Comparison of nilotinib and imatinib in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): ENESTnd beyond one year. Proc ASCO 2010;Abstract 6501. |
||||||||